N-[2-(4-fluorophenyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-7-yl]ethene-1-sulfonamide
Structure Info
- Chemspace ID
- CSSB21332052116 (In-Stock Building Blocks)
- IUPAC Name
- N-[2-(4-fluorophenyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-7-yl]ethene-1-sulfonamide
- Mol formula
- C15H15FN2O2S2
- Mol weight
- 338 Da
- Catalog Number(s)
- BBLS21332052116, EN300-54820944, bbls21332052116
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.97
- Heavy atoms count
- 22
- Rotatable bond count
- 3
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.26666666666667
- Polar surface area (Å)
- 59
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 1
![Chemical structure of N-[2-(4-fluorophenyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-7-yl]ethene-1-sulfonamide (C15H15FN2O2S2) - CSSB21332052116](/st/structure/200/43d8bb5cc14b807994154d53d985e8ff/FC1%253DCC%253DC%2528C%253DC1%2529C1%253DNC2%253DC%2528S1%2529C%2528CCC2%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png "C15H15FN2O2S2")
- Zoom the structure
- CSSB21332052116
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 491.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 514.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 538.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 561.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 584.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,147.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,695.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 2,516.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of N-[2-(4-fluorophenyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-7-yl]prop-2-enamide - CSSB00133142922](/st/structure/200/62f708f8e69aa086c81c19b8abb98a04/FC1%253DCC%253DC%2528C%253DC1%2529C1%253DNC2%253DC%2528S1%2529C%2528CCC2%2529NC%2528%253DO%2529C%253DC.png)
![Chemical structure of N-{2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]ethyl}ethene-1-sulfonamide - CSSB21332108777](/st/structure/200/273bca51038d896153ca1a4f2e4155e9/FC1%253DCC%253DC%2528C%253DC1%2529C1%253DNC%2528CCNS%2528%253DO%2529%2528%253DO%2529C%253DC%2529%253DCS1.png)
![Chemical structure of 2-chloro-2-fluoro-N-[2-(4-fluorophenyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-7-yl]acetamide - CSSB14790103308](/st/structure/200/839f03ad0c5eda466e9b489e382e26f8/FC%2528Cl%2529C%2528%253DO%2529NC1CCCC%253D2N%253DC%2528SC12%2529C%253D3C%253DCC%2528F%2529%253DCC3.png)
![Chemical structure of 2-chloro-N-[2-(4-fluorophenyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-7-yl]acetamide - CSSB02071917335](/st/structure/200/7b5b31be682aef641691c759f1fe48bc/O%253DC%2528CCl%2529NC1CCCC2%253DC1SC%2528C1%253DCC%253DC%2528F%2529C%253DC1%2529%253DN2.png)
![Chemical structure of N-{1-[2-(4-fluorophenyl)-4-methyl-1,3-thiazol-5-yl]ethyl}ethene-1-sulfonamide - CSSB21332126135](/st/structure/200/ecf4c224cfee14f9b1dadc4313294655/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DC%2528C%2529N%253DC%2528S1%2529C1%253DCC%253DC%2528F%2529C%253DC1.png)
